CUSIP Y1R80M106SHSGDTCQ4 2025
12 filings · latest Oct 29, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Susquehanna International Group, LLP | 29.8K | $39.7K |
| 2 | Two Sigma Securities, LLC | 11.9K | $15.8K |
| 3 | Stonex Group Inc. | 10.4K | $13.8K |
| 4 | Ubs Group AG | 1.1K | $1.4K |
| 5 | Osaic Holdings, Inc. | 21 | $28 |
| 4 | Mar 4, 2025 | 28 Consultants Ltd | 13G | 7.6% | 880.3K | SEC |
| 5 | May 23, 2024 | Choo Chee Kong | 13G/A | 26.6% | 3.07M | SEC |
| 6 | Feb 14, 2024 | Zeng Jieming | 13G | 5.1% | 589.2K | SEC |
| 7 | Feb 14, 2024 | Wang Shu | 13G | 7.7% | 883.9K | SEC |
| 8 | Feb 14, 2024 | Mdr Ltd | 13G | 11.6% | 1.34M | SEC |
| 9 | Feb 14, 2024 | Choo Chee Kong | 13G | 27.4% | 3.16M | SEC |
| 10 | May 19, 2023 | Zeng Jieming | 13D | 5.1% | 589.2K | SEC |
See the full Schedule 13D/13G history for Cytomed Therapeutics Limited.
Unlock full history